Continuous glucose monitoring in children with glycogen storage disease type I
ÇS Kasapkara, G Cinasal Demir… - European journal of …, 2014 - nature.com
ÇS Kasapkara, G Cinasal Demir, A Hasanoğlu, L Tümer
European journal of clinical nutrition, 2014•nature.comResults: All the patients completed the study without any major adverse events. Significant
periods of asymptomatic hypoglycemia (below 4 mmol/l, 70 mg/dl) were noted. There was a
close correlation between CGM sensor and capillary blood glucose values measured by a
glucometer. CGM indicated a considerable reduction in duration of hypoglycemia, liver size
and improvements in secondary metabolic derangements such as hyperlacticacidemia and
hyperlipidemia. Conclusions: CGM could be applied in the clinical setting to help the …
periods of asymptomatic hypoglycemia (below 4 mmol/l, 70 mg/dl) were noted. There was a
close correlation between CGM sensor and capillary blood glucose values measured by a
glucometer. CGM indicated a considerable reduction in duration of hypoglycemia, liver size
and improvements in secondary metabolic derangements such as hyperlacticacidemia and
hyperlipidemia. Conclusions: CGM could be applied in the clinical setting to help the …
Results:
All the patients completed the study without any major adverse events. Significant periods of asymptomatic hypoglycemia (below 4 mmol/l, 70 mg/dl) were noted. There was a close correlation between CGM sensor and capillary blood glucose values measured by a glucometer. CGM indicated a considerable reduction in duration of hypoglycemia, liver size and improvements in secondary metabolic derangements such as hyperlacticacidemia and hyperlipidemia.
Conclusions:
CGM could be applied in the clinical setting to help the physician to identify hypoglycemic events, and repeated CGM may serve as a safe and useful tool for the assessment of the long-term management of patients with GSD I.
nature.com